InvestorsHub Logo
Followers 279
Posts 37028
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Thursday, 07/20/2017 10:08:17 AM

Thursday, July 20, 2017 10:08:17 AM

Post# of 8449
6-26-17 PR, KTOV expects that the formal filing of the NDA by the FDA will occur by the end of the 3rd quarter of 2017.
Next paragraph:
Given the excellent results of our phase3 clinical trial were confident that KIT-302 will be approved by the FDA and become a successful treatment for osteoorthritis and hypertension.

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.